Special Issue "Alterations to Signalling Pathways in Cancer Cells"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 May 2017)
Dr. Terrence Piva
School of Health & Biomedical Sciences, RMIT University, PO Box 71 Bundoora, Victoria 3083, Australia
Website | E-Mail
Fax: +61 3 9925 7063
Interests: cell signalling; skin cancer; photobiology; photoimmunology; enzymology; cell metabolism; oxidative stress; cell death; inflammation; enzyme kinetics; metal oxide nanoparticles; sunscreens
It is well acknowledged that in most transformed and tumour cells, that intracellular signalling pathways are altered to those observed in non-transformed cells. Considerable interest has been focused on understanding how these signalling pathways have been altered, and how these differences can be used to devise potential therapeutic treatments that may enhance survival rates of these cancer patients. In the area of melanoma research, a great deal of effort has been directed to understanding how those cells containing the BRAFV600E mutation can overcome treatment with specific inhibitors, such as vemurafenib. This Special Issue of the International Journal of Molecular Sciences, “Alterations to Signalling Pathways in Cancer Cells”, will focus on how intracellular signalling pathways are altered in tumour cells. Authors are invited to submit manuscripts that compare how these pathways differ to that seen in untransformed cells, and how they differ to that seen in untransformed cells or in tumour cells undergoing treatment. The results from these studies may provide useful information in devising treatments that may enhance survival rates of cancer patients.
Dr. Terrence Piva
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Tumour suppressor genes
- Cell survival